Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eksp Klin Farmakol ; 78(1): 21-6, 2015.
Artigo em Russo | MEDLINE | ID: mdl-25826870

RESUMO

The paper reviews the preliminary results of a multicenter randomized clinical research. The aim of the study was to determine the optimal duration of different types of energy-correction therapy. 99 case report forms of patients with cerebral infarction were reviewed with their prior envelope randomization into three groups. Patients in the first group (experimental group), consisting of 32 patients, as part of combined therapy received ascorbic acid (5% solution twice a day in a recommended dosage of 20 ml/day for 20 days); the second group (37 patients) received 10 ml of cytoflavin intravenously by drop infusion twice a day for 10 days; the third group received cytoflavin for 20 days (from day 1 to day 10 - 20 ml a day, from day 11 to day 20 - 10 ml a day). The average NIH scale score on admission was 14.9 ± 2.6. Prescription of cytoflavin came with average 1.7 - 1.8 time regression (p < 0.05) of the volumes of cerebral ischemia in the of cases of the 10- and 20-day courses of treatment, while there were no significant morphologic changes in the ascorbic acid group. These results correlated with the best dynamics and outcomes of the neurological and performance status of patients receiving cytoflavin. Despite the lack of significant general differences in the clinical and morphological data of the second and third groups, the patients with underlying grave medical condition in the 20-day cytoflavin group (with NIH score of 14-20 points on admission) tended to have improved neurologic status parameters in comparison with the experimental group and the 10-day cytoflavin group. These results attest to the advantages of personalized antioxidant energy-correction therapy.


Assuntos
Antioxidantes/uso terapêutico , Ácido Ascórbico/uso terapêutico , Infarto Cerebral/tratamento farmacológico , Mononucleotídeo de Flavina/uso terapêutico , Inosina Difosfato/uso terapêutico , Niacinamida/uso terapêutico , Succinatos/uso terapêutico , Idoso , Infarto Cerebral/patologia , Infarto Cerebral/fisiopatologia , Cognição/efeitos dos fármacos , Esquema de Medicação , Combinação de Medicamentos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Medicina de Precisão , Testes Psicológicos , Federação Russa , Índice de Gravidade de Doença , Resultado do Tratamento
2.
Artigo em Russo | MEDLINE | ID: mdl-15717539

RESUMO

How intensive rehabilitation influences external respiration function, central and peripheral hemodynamics in the injured with a severe multitrauma was investigated in 71 injured. Intensive rehabilitation in combined treatment is shown to improve external respiration function, central hemodynamics, tissue blood flow, sleep, appetite, healing of bedsores, to enhance cough reflex.


Assuntos
Traumatismo Múltiplo/reabilitação , Modalidades de Fisioterapia , Insuficiência Respiratória/terapia , Adulto , Hemodinâmica , Humanos , Massagem , Pessoa de Meia-Idade , Traumatismo Múltiplo/fisiopatologia , Traumatismo Múltiplo/terapia , Insuficiência Respiratória/fisiopatologia , Insuficiência Respiratória/reabilitação , Capacidade Vital
3.
Khirurgiia (Mosk) ; (12): 24-6, 2003.
Artigo em Russo | MEDLINE | ID: mdl-14671600

RESUMO

Blood linear velocity in inferior cava vein was measured in 74 persons (men and women) aged from 18 to 55 years including 29 healthy volunteers and 45 patients with various severity of trauma and different assessment of its severity by APACHE-2 scale. Correlation between APACHE-2 index and changes of ratio of blood linear velocities in inferior cava vein was demonstrated. It is concluded that ratio of blood linear velocities in inferior cava vein can be used as a criterion of treatment efficacy in patients with combined trauma in early postoperative period.


Assuntos
Velocidade do Fluxo Sanguíneo , Traumatismo Múltiplo/diagnóstico , Veia Cava Inferior/fisiologia , APACHE , Traumatismos Abdominais/diagnóstico , Adolescente , Adulto , Lesões Encefálicas/diagnóstico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Traumatismo Múltiplo/mortalidade , Traumatismo Múltiplo/terapia , Respiração Artificial , Fatores de Risco , Traumatismos da Coluna Vertebral/diagnóstico , Traumatismos Torácicos/diagnóstico , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...